Products
Test Reference
This indicates the pharmacopoeial standards or guidelines followed for testing the product to ensure its quality, purity, and safety. Common pharmacopoeial references include
| SNO | Product Name | Test Reference | Type of Cancers treated |
|---|---|---|---|
| 1 | Nilutamide | Ph.Eur | Prostate cancer |
| 2 | Cisplatin | USP/Ph.Eur/BP/IP | Bladder/ovaries/ testicals cancers |
| 3 | Melphalan (1) | IP/USP | Breast cancer / childhood neuroblastoma |
| Melphalan hydrochloride (2) | IHS | Multiple myeloma/ overian cancer | |
| 4 | Temozolomide | USP/IP | Brain cancer |
| 5 | Oxaliplatin | USP/Ph.Eur/BP | Advanced colon / rectal cancer |
| 6 | Carboplatin | USP/Ph.Eur/BP | Ovarian cancer |
| 7 | Carmustine | USP/Ph.Eur/BP | Brain tumor/ Non Hodgkin's lyphoma / Hodgkin's lyphoma |
| 8 | Docetaxel Trihydrate(1) | Ph.Eur/IP/BP | Breast / lung/ head/ neck/ stomach cancers |
| Docetaxel Trihydrate(2) | USP | Breast / Ovarian / lungs cancer | |
| 9 | Pemetrexed Disodium | USP | Non- small cell lung cancer/ malignant plerual mesothelioma |
| 10 | Gemcitabine hydrochloride | USP/Ph.Eur/BP | Pancreatic / breast / lung cancers |
| 11 | Aminoglutethimide | USP | Tumors that affects adrenal cortex |
| 12 | Taurolidine | IHS | CRBSI |
| 13 | Irinotecan HCL Trihydrate | USP | Gastrointestinal cancers |
| 14 | Crizotinib | IHS | Non-small cell lung cancer (NSCLC |
| 15 | Thiotepa | IP | Urinary bladder/ breast / ovarian cancer |
| 16 | Trientine hydrochloride | USP | Wilsons Disease |
| Trientine Hcl | USP | Wilsons Disease | |
| 17 | Paclitaxel | USP/Ph.Eur/BP/IP | Advanced cancer of the ovaries, breast, non-small cell lung cancer, and Kaposi sarcoma |
| 18 | Bortezomib | IP | Multiple myeloma (blood plasma cell cancer) in patients with or without a previous history of treatment, and mantle cell lymphoma |
| 19 | Vinorelbine Tartrate | USP/Ph.Eur/BP/IP | Treatment of advanced non-small cell lung cancer (NSCLC), as a single therapy or in combination with other chemotherapeutic drugs |
| 20 | Dasatinib Monohydrate | IHS | Types of leukemia in adults and children |
| 21 | Vinblastine sulphate | USP/Ph.Eur/BP/IP | Breast cancer that has not gotten better with other treatment |
| 22 | Vincristine Sulphate | USP/Ph.Eur/IP | Treat various types of cancer, including leukemia, lymphoma, neuroblastoma, and Wilms tumor |
| 23 | Cytarabine | USP/Ph.Eur/BP/IP | Treat certain types of leukemia (cancer of the white blood cells), including acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), and chronic myelogenous leukemia (CML). |
| 24 | Etoposide | USP/Ph.Eur/BP/IP | Treat small cell lung cancer. |
| 25 | Methotrexate | USP/Ph.Eur/BP/IP | Treats inflammatory conditions such as arthritis and psoriasis |
| 26 | Fludarabine phosphate | Ph.Eur/IHS | Treat B-cell chronic lymphocytic leukemia (CLL) |
| 27 | Imatinib Mesylate | IP/Ph.Eur | Treat different types of cancer or bone marrow conditions |
| 28 | Fulvestrant | USP/IP | Fulvestrant injection is used alone or in combination with another chemotherapy medication to treat a certain type of hormone receptor positive, advanced breast cancer |
| 29 | Capecitabine | USP/IP | Used alone or in combination with other cancer treatments in patients with colon cancer that has spread (Stage III) to help prevent colon cancer from coming back after surgery |
| 30 | 5- Fluorouracil | USP/BP/EP/IP | Treat certain cancers and skin conditions. |
| 31 | Abiraterone Acetate | USP/IP | Treat a certain type of prostate cancer that has spread to other parts of the body. |
| 32 | Calcium Folinate | USP/BP/EP/IP | To diminish the toxicity and counteract the action of folate antagonists, such as methotrexate. |
| 33 | Trofosfamide | IHS | Treatment of soft-tissue sarcoma. |
| 34 | Zoledronic Acid | IP | Treats Paget's disease and osteoporosis |
| 35 | Chlorambucil | USP/BP/EP/IP | Treat different types of cancer of the blood and lymph system, such as chronic lymphatic leukemia, Hodgkin's disease, and other types of lymphoma. |
| 36 | Bleomycin sulfate | USP/BP/EP/IP | Treat various types of cancer, including cervical cancer, head and neck cancers, testicular cancer, and certain types of lymphoma |
| 37 | Mesna | BP/EP/IP | To lower the risk of inflammation and bleeding of the bladder (hemorrhagic cystitis) in patients who receive ifosfamide (cancer medicine) |
| 38 | Mitomycin | USP/BP/EP/IP | Treatment of anal carcinoma, bladder carcinoma, breast carcinoma, head and neck malignancies, and some other gastrointestinal carcinomas. |
| 39 | Ifosfamide | USP/IP | Treat certain types of cancer |
| 40 | Exemestane | IP | Treat early and advanced breast cancer in women who have already stopped menstruating (postmenopausal) |